Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study

Background Platelet transfusion is indicated for haemorrhage due to severe thrombocytopenia and for trauma associated coagulopathy. Febrile non-haemolytic transfusion reactions are a common complication of platelet transfusions in people and may be due to accumulated inflammatory cytokines. The pres...

Full description

Bibliographic Details
Main Authors: Robert Goggs, Signe Cremer, Marjory B. Brooks
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:Veterinary Record Open
Online Access:https://vetrecordopen.bmj.com/content/7/1/e000366.full
id doaj-2f1fb4338e024f2ab14864f31b511be3
record_format Article
spelling doaj-2f1fb4338e024f2ab14864f31b511be32021-06-02T15:31:29ZengWileyVeterinary Record Open2052-61132020-12-017110.1136/vetreco-2019-000366Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary studyRobert Goggs0Signe Cremer1Marjory B. Brooks2Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, New York, USADepartment of Veterinary Clinical Sciences, University of Copenhagen, Frederiksberg C, DenmarkPopulation Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine, Ithaca, New York, USABackground Platelet transfusion is indicated for haemorrhage due to severe thrombocytopenia and for trauma associated coagulopathy. Febrile non-haemolytic transfusion reactions are a common complication of platelet transfusions in people and may be due to accumulated inflammatory cytokines. The present study aimed to determine the cytokine profile of a novel canine lyophilised platelet product following reconstitution, to assess the lyophilised platelets’ activation response to physiological platelet agonists and to compare the cytokine profiles of basal and stimulated canine lyophilised platelets.Methods Cell counts and biochemical analyses were conducted following reconstitution. Cytokine concentrations were measured with a canine-specific multiplex immunocapture assay and with an electrochemiluminescent ELISA. Aliquots of reconstituted product from three separate vials were activated for 10 minutes under non-stirred conditions using adenosine diphosphate, thrombin or convulxin and their cytokine concentrations compared with unactivated samples. Flow cytometry and light-transmission aggregometry were used to evaluate the product’s ability to express a procoagulant surface, degranulate and aggregate. Fresh platelet-rich plasma was used as a positive control.Results The product had a mean±SD particle count of 1.23±0.2×109/ml, contained platelets that expressed surface phosphatidylserine before agonist stimulation and was capable of aggregation in response to thrombin stimulation suggesting that the product may have haemostatic potential following in vivo administration. Cytokine concentrations measured by the immunocapture assay were generally low, while twofold to threefold increases relative to published intervals were noted for several cytokines using the ELISA. Concentrations of chemokine (C-X-C) motif ligand 8 and tumour necrosis factor-α were significantly increased as measured by the ELISA, but not by the immunocapture assay, while concentrations of KC-like were significantly increased as measured by the immunocapture assay. Stimulation with platelet agonists did not affect measured cytokine concentrations.Conclusion Further study of the effects of administration of this lyophilised platelet product is warranted.https://vetrecordopen.bmj.com/content/7/1/e000366.full
collection DOAJ
language English
format Article
sources DOAJ
author Robert Goggs
Signe Cremer
Marjory B. Brooks
spellingShingle Robert Goggs
Signe Cremer
Marjory B. Brooks
Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study
Veterinary Record Open
author_facet Robert Goggs
Signe Cremer
Marjory B. Brooks
author_sort Robert Goggs
title Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study
title_short Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study
title_full Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study
title_fullStr Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study
title_full_unstemmed Evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study
title_sort evaluation of cytokine concentrations in a trehalose-stabilised lyophilised canine platelet product: a preliminary study
publisher Wiley
series Veterinary Record Open
issn 2052-6113
publishDate 2020-12-01
description Background Platelet transfusion is indicated for haemorrhage due to severe thrombocytopenia and for trauma associated coagulopathy. Febrile non-haemolytic transfusion reactions are a common complication of platelet transfusions in people and may be due to accumulated inflammatory cytokines. The present study aimed to determine the cytokine profile of a novel canine lyophilised platelet product following reconstitution, to assess the lyophilised platelets’ activation response to physiological platelet agonists and to compare the cytokine profiles of basal and stimulated canine lyophilised platelets.Methods Cell counts and biochemical analyses were conducted following reconstitution. Cytokine concentrations were measured with a canine-specific multiplex immunocapture assay and with an electrochemiluminescent ELISA. Aliquots of reconstituted product from three separate vials were activated for 10 minutes under non-stirred conditions using adenosine diphosphate, thrombin or convulxin and their cytokine concentrations compared with unactivated samples. Flow cytometry and light-transmission aggregometry were used to evaluate the product’s ability to express a procoagulant surface, degranulate and aggregate. Fresh platelet-rich plasma was used as a positive control.Results The product had a mean±SD particle count of 1.23±0.2×109/ml, contained platelets that expressed surface phosphatidylserine before agonist stimulation and was capable of aggregation in response to thrombin stimulation suggesting that the product may have haemostatic potential following in vivo administration. Cytokine concentrations measured by the immunocapture assay were generally low, while twofold to threefold increases relative to published intervals were noted for several cytokines using the ELISA. Concentrations of chemokine (C-X-C) motif ligand 8 and tumour necrosis factor-α were significantly increased as measured by the ELISA, but not by the immunocapture assay, while concentrations of KC-like were significantly increased as measured by the immunocapture assay. Stimulation with platelet agonists did not affect measured cytokine concentrations.Conclusion Further study of the effects of administration of this lyophilised platelet product is warranted.
url https://vetrecordopen.bmj.com/content/7/1/e000366.full
work_keys_str_mv AT robertgoggs evaluationofcytokineconcentrationsinatrehalosestabilisedlyophilisedcanineplateletproductapreliminarystudy
AT signecremer evaluationofcytokineconcentrationsinatrehalosestabilisedlyophilisedcanineplateletproductapreliminarystudy
AT marjorybbrooks evaluationofcytokineconcentrationsinatrehalosestabilisedlyophilisedcanineplateletproductapreliminarystudy
_version_ 1721403226221182976